Want to join the conversation?
Health care company $MRK said it has acquired IOmet, a UK-based drug discovery company focused on developing cancer medications. Under the terms of the agreement, $MRK, through a subsidiary, will acquire IOmet, and IOmet will become a wholly-owned subsidiary of $MRK. Financial terms of the acquisition were not disclosed.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.